Sign in

    CVS Health Corp (CVS)

    You might also like

    CVS Health Corporation is a leading health solutions company that operates across four main segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other . The company offers a wide range of health insurance products and services, pharmacy benefit management solutions, and retail pharmacy operations . CVS Health leverages its integrated model to enhance care delivery, improve health outcomes, and reduce health care costs .

    1. Pharmacy & Consumer Wellness - Operates retail pharmacy services, long-term care pharmacy services, specialty and mail order pharmacy offerings, and front store sales, which include health and wellness products and general merchandise .
    2. Health Care Benefits - Offers health insurance products and services, including medical, pharmacy, dental, and behavioral health plans, as well as Medicare Advantage and Medicaid management services .
    3. Health Services - Provides pharmacy benefit management solutions and health care services through medical clinics, virtual platforms, and home-based care, supported by acquisitions like Signify Health and Oak Street Health .
    4. Corporate/Other - Includes management and administrative expenses and products for which the company no longer solicits new customers .
    NamePositionExternal RolesShort Bio

    Karen S. Lynch

    ExecutiveBoard

    President and CEO

    None

    Karen Lynch has been CEO since February 2021, leading CVS's transformation into a consumer-centric healthcare company.

    J. David Joyner

    Executive

    President and CEO

    Advisory Council Member, Rawls College of Business, Texas Tech University

    Appointed CEO in October 2024; previously EVP and President of Pharmacy Services.

    Prem S. Shah

    Executive

    EVP and Group President

    None

    Oversees CVS Caremark, CVS Pharmacy, and healthcare delivery businesses; joined CVS in 2013.

    Samrat S. Khichi

    Executive

    EVP, Chief Policy Officer, and General Counsel

    None

    Joined CVS in February 2023; oversees public policy, compliance, and legal functions, and supported major acquisitions.

    Steve Nelson

    Executive

    EVP and President of Aetna

    None

    Former CEO of UnitedHealthcare; leads Aetna's operations and strategy.

    Thomas F. Cowhey

    Executive

    EVP and CFO

    None

    Appointed CFO in January 2024 after serving as interim CFO; oversees financial strategy and operations.

    Tilak Mandadi

    Executive

    EVP, Chief Digital, Data, Analytics, and Technology Officer

    None

    Leads CVS's digital transformation, driving innovation and customer engagement; joined in July 2022.

    Alecia A. DeCoudreaux

    Board

    Director

    Lead Independent Trustee, Parnassus Funds

    Former President of Mills College; brings pharmaceutical and corporate governance expertise.

    Anne M. Finucane

    Board

    Director

    Chair, Rubicon Carbon; Senior Advisor, TPG Climate Rise Fund; Director, Williams Sonoma

    Former Vice Chair at Bank of America; recognized for ESG leadership and corporate strategy expertise.

    C. David Brown II

    Board

    Director

    Partner, Nelson Mullins Riley & Scarborough LLP

    Legal expert with extensive healthcare governance experience; joined CVS Board in 2007.

    Doug Shulman

    Board

    Director

    Chairman and CEO, OneMain Holdings; Board Member, Carnegie Foundation for the Advancement of Teaching

    Former IRS Commissioner; brings financial and regulatory expertise.

    Fernando Aguirre

    Board

    Director

    Director, Barry Callebaut AG; Director, Synchrony Financial

    Former CEO of Chiquita Brands; brings global business and brand management expertise.

    Guy Sansone

    Board

    Director

    Chairman and CEO, H2 Health; Lead Independent Director, Pediatrix Medical Group; Board Member, ChenMed

    Healthcare advisor and investor with over 30 years of experience in strategy and operations.

    J. Scott Kirby

    Board

    Director

    CEO, United Airlines; Chairman, Star Alliance Chief Executive Board

    CEO of United Airlines; brings expertise in marketing, sales, and network planning.

    Jean-Pierre Millon

    Board

    Director

    None

    Former CEO of PCS Health Systems; brings pharmacy benefit management and pharmaceutical expertise.

    Jeffrey R. Balser

    Board

    Director

    President and CEO, Vanderbilt University Medical Center; Dean, Vanderbilt University School of Medicine

    Brings expertise in healthcare delivery, personalized medicine, and financial oversight.

    Larry Robbins

    Board

    Director

    CEO, Glenview Capital Management; Lead Independent Director, Butterfly Network

    Founder of Glenview Capital; brings extensive healthcare investment expertise.

    Leslie Norwalk

    Board

    Director

    Board Member, Arvinas, ModivCare, Neurocrine Biosciences, Globus Medical

    Former Acting Administrator of CMS; brings healthcare policy and regulatory expertise.

    Mary L. Schapiro

    Board

    Director

    Director, Morgan Stanley; Vice Chair, Bloomberg L.P.

    Former SEC Chair; brings expertise in legal, regulatory compliance, and corporate governance.

    Michael F. Mahoney

    Board

    Director

    Chairman, President, and CEO, Boston Scientific Corporation

    CEO of Boston Scientific; brings healthcare innovation and operational expertise.

    Nancy-Ann M. DeParle

    Board

    Director

    Managing Partner, Consonance Capital Partners; Director, HCA Healthcare; Trustee, Duke University

    Former White House healthcare policy leader; brings over 25 years of healthcare sector experience.

    Roger N. Farah

    Board

    Executive Chair of the Board

    Director, The Progressive Corporation

    Former Chair of the Board; brings over 40 years of retail industry experience.

    1. Given that your Health Care Benefits segment may show operating losses in 2024 after generating over $5.5 billion in adjusted operating income in 2023 , what are the primary factors driving this significant decline, and what specific measures are you implementing to return this business to profitability?

    2. You acknowledged miscalculations during the 2023 bid process for Medicare Advantage and individual exchange products, which significantly burdened Aetna's current results . How are you adjusting your bid and pricing strategies to prevent similar issues in future cycles, and what oversight mechanisms are being implemented to ensure accuracy?

    3. With the anticipated Medicare Advantage membership disenrollment of 5% to 10% due to benefit design changes and reduced supplemental benefits , how do you plan to maintain market competitiveness and member satisfaction while aiming for margin improvement?

    4. The individual exchange business is facing higher utilization and may result in negative margins approaching double digits . What are the underlying factors contributing to this underperformance, and what corrective actions are you taking to stabilize and improve this business line?

    5. Given that Aetna has been more acutely impacted by industry pressures than others , what structural or operational deficiencies have you identified, and how will the recent leadership changes and operational enhancements address these issues effectively?

    Program DetailsProgram 1Program 2
    Approval DateDecember 9, 2021November 17, 2022
    End Date/DurationNot specifiedNot specified
    Total additional amount$10.0 billion $10.0 billion
    Remaining authorization amount$1.5 billion $10.0 billion
    DetailsNo specific end date providedNo shares repurchased yet

    Competitors mentioned in the company's latest 10K filing.

    CompanyDescription

    The retail pharmacy business is highly competitive, and the company competes with other drugstore chains, including this competitor, in the areas it serves. The competition is based on store location and convenience, customer service and satisfaction, product selection and variety, and price.

    Rite Aid

    The retail pharmacy business is highly competitive, and the company competes with other drugstore chains, including this competitor, in the areas it serves. The competition is based on store location and convenience, customer service and satisfaction, product selection and variety, and price.

    The company competes with discount retailers, including this competitor, in the areas it serves. The competition is based on store location and convenience, customer service and satisfaction, product selection and variety, and price.

    The company competes with online retailers, including this competitor, in the areas it serves. The competition is based on store location and convenience, customer service and satisfaction, product selection and variety, and price.

    PharMerica

    The company's largest LTC pharmacy competitor nationally is this competitor. The company also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities, and local retail pharmacies.

    Prime Therapeutics

    The Health Services segment has a significant number of competitors offering PBM services, including large, national PBM companies such as this competitor.

    MedImpact

    The Health Services segment has a significant number of competitors offering PBM services, including large, national PBM companies such as this competitor.

    Express Scripts

    The Health Services segment competes with PBMs owned by large national health plans, including the business of this competitor.

    OptumRx

    The Health Services segment competes with PBMs owned by large national health plans, including the business of this competitor.

    Aledade

    The company's primary care operations compete with large and medium-sized local and national providers of primary care services, such as this competitor.

    Centerwell

    The company's primary care operations compete with large and medium-sized local and national providers of primary care services, such as this competitor.

    Collaborative Health Systems

    The company's ACO operations compete with healthcare risk management providers, including this competitor, which operates nationally.

    The company's ACO operations compete with healthcare risk management providers, including this competitor, which operates nationally.

    Vytalize Health

    The company's ACO operations compete with healthcare risk management providers, including this competitor, which operates nationally.

    Stellar Health

    The company's ACO operations compete with healthcare risk management providers, including this competitor, which operates nationally.

    Equality Health

    The company's ACO operations compete with healthcare risk management providers, including this competitor, which is more geographically focused.

    Physicians of Southwest Washington

    The company's ACO operations compete with healthcare risk management providers, including this competitor, which is more geographically focused.

    Matrix Medical Network

    The company's IHE and related services operations compete with a wide variety of local and national providers of in-home, virtual, and in-person diagnostic and evaluative services, including pure-play companies whose principal business is providing health risk assessments and similar services, such as this competitor.

    NameStart DateEnd DateReason for Change
    Ernst & Young LLP2007 PresentCurrent auditor

    Notable M&A activity and strategic investments in the past 3 years.

    CompanyYearDetails

    Oak Street Health, Inc.

    2023

    Acquired by CVS Health on May 2, 2023 for $39.00 per share in cash, financed through $5.0 billion in borrowings and existing cash resources to expand its value-based primary care strategy; final purchase accounting adjustments were completed in Q2 2024.

    Signify Health, Inc.

    2023

    Acquisition completed in 2023; CVS Health acquired the company to leverage its expertise in health risk assessments, value-based care, and provider enablement services, with integration costs recorded in 2024 under the Corporate/Other segment.

    Recent press releases and 8-K filings for CVS.

    CVS Health Announces CFO & CMO Leadership Changes and FY2025 Guidance Update
    CVS
    CFO Change
    Management Change
    Guidance Update
    • Brian Newman is appointed CFO designate effective April 21, with Tom Cowhey transitioning to a senior/strategic advisory role effective May 12
    • Amy Compton-Phillips, M.D. is named Chief Medical Officer, effective May 19, to help drive improved health care delivery
    • The company expects its full-year 2025 guidance to meet or exceed previous estimates based on strong year-to-date performance
    Apr 8, 2025, 12:00 AM